J&J in deal to supply COVID-19 vaccines to African Union member states

Johnson & Johnson said on Monday that its unit, Janssen Pharmaceutica NV, entered into a deal with the African Vaccine Acquisition Trust (AVAT) to make available up to 220 million doses of its single-shot COVID-19 vaccine candidate.

The company said that the delivery of these vaccines to the African Union's 55 member states will begin in the third quarter of 2021.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)